Macrophages and microglia: the cerberus of glioblastoma
- PMID: 33766119
- PMCID: PMC7992800
- DOI: 10.1186/s40478-021-01156-z
Macrophages and microglia: the cerberus of glioblastoma
Abstract
Glioblastoma (GBM) is the most aggressive and deadliest of the primary brain tumors, characterized by malignant growth, invasion into the brain parenchyma, and resistance to therapy. GBM is a heterogeneous disease characterized by high degrees of both inter- and intra-tumor heterogeneity. Another layer of complexity arises from the unique brain microenvironment in which GBM develops and grows. The GBM microenvironment consists of neoplastic and non-neoplastic cells. The most abundant non-neoplastic cells are those of the innate immune system, called tumor-associated macrophages (TAMs). TAMs constitute up to 40% of the tumor mass and consist of both brain-resident microglia and bone marrow-derived myeloid cells from the periphery. Although genetically stable, TAMs can change their expression profiles based upon the signals that they receive from tumor cells; therefore, heterogeneity in GBM creates heterogeneity in TAMs. By interacting with tumor cells and with the other non-neoplastic cells in the tumor microenvironment, TAMs promote tumor progression. Here, we review the origin, heterogeneity, and functional roles of TAMs. In addition, we discuss the prospects of therapeutically targeting TAMs alone or in combination with standard or newly-emerging GBM targeting therapies.
Keywords: Glioblastoma; Heterogeneity; Macrophages; Microenvironment; Microglia.
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Immune Microenvironment in Glioblastoma Subtypes.Front Immunol. 2018 May 8;9:1004. doi: 10.3389/fimmu.2018.01004. eCollection 2018. Front Immunol. 2018. PMID: 29867979 Free PMC article. Review.
-
Neuroinflammation in Glioblastoma: The Role of the Microenvironment in Tumour Progression.Curr Cancer Drug Targets. 2024;24(6):579-594. doi: 10.2174/0115680096265849231031101449. Curr Cancer Drug Targets. 2024. PMID: 38310461 Review.
-
Enhancing Glioblastoma Immunotherapy with Integrated Chimeric Antigen Receptor T Cells through the Re-Education of Tumor-Associated Microglia and Macrophages.ACS Nano. 2024 Apr 30;18(17):11165-11182. doi: 10.1021/acsnano.4c00050. Epub 2024 Apr 16. ACS Nano. 2024. PMID: 38626338
-
Distinct regional ontogeny and activation of tumor associated macrophages in human glioblastoma.Sci Rep. 2020 Nov 11;10(1):19542. doi: 10.1038/s41598-020-76657-3. Sci Rep. 2020. PMID: 33177572 Free PMC article.
-
GBM Immunotherapy: Macrophage Impacts.Immunol Invest. 2024 Jul;53(5):730-751. doi: 10.1080/08820139.2024.2337022. Epub 2024 Apr 18. Immunol Invest. 2024. PMID: 38634572 Review.
Cited by
-
Pro-inflammatory cytokines mediate the epithelial-to-mesenchymal-like transition of pediatric posterior fossa ependymoma.Nat Commun. 2022 Jul 8;13(1):3936. doi: 10.1038/s41467-022-31683-9. Nat Commun. 2022. PMID: 35803925 Free PMC article.
-
Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics.Curr Oncol. 2024 Apr 14;31(4):2233-2243. doi: 10.3390/curroncol31040165. Curr Oncol. 2024. PMID: 38668068 Free PMC article.
-
Malignant Cells Beyond the Tumor Core: The Non-Negligible Factor to Overcome the Refractory of Glioblastoma.CNS Neurosci Ther. 2025 Mar;31(3):e70333. doi: 10.1111/cns.70333. CNS Neurosci Ther. 2025. PMID: 40104956 Free PMC article. Review.
-
Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies.Pharmaceutics. 2022 Aug 24;14(9):1762. doi: 10.3390/pharmaceutics14091762. Pharmaceutics. 2022. PMID: 36145510 Free PMC article. Review.
-
Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma.Nat Commun. 2024 Jan 2;15(1):131. doi: 10.1038/s41467-023-44576-2. Nat Commun. 2024. PMID: 38167409 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical